ArticleBritish journal of cancer2024

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

F Poumeaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.